Terms: = Prostate cancer AND TLX1, P31314, 3195, ENSG00000107807, TCL3, HOX11
10 results:
1. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
World J Urol; 2024 Mar; 42(1):152. PubMed ID: 38483586
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with prostate cancer After Robot-Assisted Radical prostatectomy (The MSUG94 Group).
Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Ann Surg Oncol; 2024 Mar; 31(3):2154-2162. PubMed ID: 38200385
[TBL] [Abstract] [Full Text] [Related]
3. Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-prostatectomy Outcomes Among prostate cancer Patients.
Mao J; Genkinger JM; Rundle AG; Wright JD; Schymura MJ; Insaf TZ; Hu JC; Tehranifar P
Ann Surg Oncol; 2024 Feb; 31(2):1373-1383. PubMed ID: 37880515
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic differences among the positive surgical margin locations following robot-assisted radical prostatectomy in a large Japanese cohort (the MSUG94 group).
Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
Jpn J Clin Oncol; 2023 Apr; 53(5):443-451. PubMed ID: 36708227
[TBL] [Abstract] [Full Text] [Related]
5. The Impact of Gleason Grade 3 as a Predictive Factor for Biochemical Recurrence after Robot-Assisted Radical prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 35893105
[No Abstract] [Full Text] [Related]
6. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
[TBL] [Abstract] [Full Text] [Related]
7. prostate cancer Brain Metastases: A Single-Institution Experience.
Bhambhvani HP; Greenberg DR; Srinivas S; Hayden Gephart M
World Neurosurg; 2020 Jun; 138():e445-e449. PubMed ID: 32147556
[TBL] [Abstract] [Full Text] [Related]
8. Complications of the first 500 extra-peritoneal robot-assisted radical prostatectomy (EP-RARP) cases in an Italian medium volume centre.
Fulcoli V; Andrisano A; Costa G; Laurini L
Urologia; 2016 Sep; 83(3):152-162. PubMed ID: 27103094
[TBL] [Abstract] [Full Text] [Related]
9. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; ; ; ; ; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
PLoS Genet; 2014 Feb; 10(2):e1004129. PubMed ID: 24550738
[TBL] [Abstract] [Full Text] [Related]
10. Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focality in prostate cancer.
Karavitakis M; Ahmed HU; Abel PD; Hazell S; Winkler MH
J Endourol; 2012 May; 26(5):503-8. PubMed ID: 22142404
[TBL] [Abstract] [Full Text] [Related]
